nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—KCNMA1—pulmonary artery—chronic obstructive pulmonary disease	0.0733	0.27	CbGeAlD
Diazoxide—ATP1A1—Ion transport by P-type ATPases—ATP2C2—chronic obstructive pulmonary disease	0.0203	0.12	CbGpPWpGaD
Diazoxide—SLC12A3—respiratory system—chronic obstructive pulmonary disease	0.0178	0.0658	CbGeAlD
Diazoxide—GLUL—respiratory system—chronic obstructive pulmonary disease	0.0133	0.049	CbGeAlD
Diazoxide—GLUL—connective tissue—chronic obstructive pulmonary disease	0.0117	0.0432	CbGeAlD
Diazoxide—GLUL—bronchus—chronic obstructive pulmonary disease	0.0109	0.0404	CbGeAlD
Diazoxide—GLUL—smooth muscle tissue—chronic obstructive pulmonary disease	0.0107	0.0395	CbGeAlD
Diazoxide—KCNMA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00994	0.0366	CbGeAlD
Diazoxide—GLUL—trachea—chronic obstructive pulmonary disease	0.00983	0.0362	CbGeAlD
Diazoxide—SLC12A3—lung—chronic obstructive pulmonary disease	0.00947	0.0349	CbGeAlD
Diazoxide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00937	0.0346	CbGeAlD
Diazoxide—ABCC8—smooth muscle tissue—chronic obstructive pulmonary disease	0.00926	0.0341	CbGeAlD
Diazoxide—ATP1A1—respiratory system—chronic obstructive pulmonary disease	0.00793	0.0292	CbGeAlD
Diazoxide—CA1—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00715	0.0423	CbGpPWpGaD
Diazoxide—GLUL—lung—chronic obstructive pulmonary disease	0.00706	0.026	CbGeAlD
Diazoxide—ATP1A1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00704	0.0416	CbGpPWpGaD
Diazoxide—ATP1A1—connective tissue—chronic obstructive pulmonary disease	0.00698	0.0257	CbGeAlD
Diazoxide—GLUL—Amino acid and derivative metabolism—APIP—chronic obstructive pulmonary disease	0.00672	0.0397	CbGpPWpGaD
Diazoxide—Feeling hot—Salbutamol—chronic obstructive pulmonary disease	0.00662	0.0118	CcSEcCtD
Diazoxide—KCNMA1—lung—chronic obstructive pulmonary disease	0.00655	0.0242	CbGeAlD
Diazoxide—ATP1A1—bronchus—chronic obstructive pulmonary disease	0.00652	0.0241	CbGeAlD
Diazoxide—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00647	0.0116	CcSEcCtD
Diazoxide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.00642	0.0115	CcSEcCtD
Diazoxide—ATP1A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00638	0.0235	CbGeAlD
Diazoxide—ATP1A1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00627	0.0371	CbGpPWpGaD
Diazoxide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00607	0.0224	CbGeAlD
Diazoxide—Gout—Formoterol—chronic obstructive pulmonary disease	0.0059	0.0105	CcSEcCtD
Diazoxide—Gout—Arformoterol—chronic obstructive pulmonary disease	0.0059	0.0105	CcSEcCtD
Diazoxide—ATP1A1—trachea—chronic obstructive pulmonary disease	0.00586	0.0216	CbGeAlD
Diazoxide—KCNJ11—Type II diabetes mellitus—ADIPOQ—chronic obstructive pulmonary disease	0.0055	0.0325	CbGpPWpGaD
Diazoxide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00535	0.0197	CbGeAlD
Diazoxide—Hirsutism—Prednisolone—chronic obstructive pulmonary disease	0.00513	0.00917	CcSEcCtD
Diazoxide—CA2—bronchus—chronic obstructive pulmonary disease	0.005	0.0184	CbGeAlD
Diazoxide—CA1—lung—chronic obstructive pulmonary disease	0.00498	0.0184	CbGeAlD
Diazoxide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00489	0.018	CbGeAlD
Diazoxide—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00478	0.00854	CcSEcCtD
Diazoxide—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00465	0.00831	CcSEcCtD
Diazoxide—ABCC8—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00465	0.0275	CbGpPWpGaD
Diazoxide—KCNJ11—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00451	0.0266	CbGpPWpGaD
Diazoxide—CA2—trachea—chronic obstructive pulmonary disease	0.00449	0.0166	CbGeAlD
Diazoxide—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.00442	0.0079	CcSEcCtD
Diazoxide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0044	0.00786	CcSEcCtD
Diazoxide—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00431	0.0255	CbGpPWpGaD
Diazoxide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00428	0.00764	CcSEcCtD
Diazoxide—ATP1A1—lung—chronic obstructive pulmonary disease	0.00421	0.0155	CbGeAlD
Diazoxide—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00419	0.00749	CcSEcCtD
Diazoxide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00409	0.00732	CcSEcCtD
Diazoxide—GLUL—Amino acid and derivative metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00403	0.0238	CbGpPWpGaD
Diazoxide—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00402	0.00719	CcSEcCtD
Diazoxide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00399	0.00713	CcSEcCtD
Diazoxide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00386	0.0069	CcSEcCtD
Diazoxide—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00386	0.00689	CcSEcCtD
Diazoxide—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.00373	0.00666	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00365	0.0216	CbGpPWpGaD
Diazoxide—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00364	0.0065	CcSEcCtD
Diazoxide—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00364	0.0065	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00354	0.0209	CbGpPWpGaD
Diazoxide—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00353	0.0063	CcSEcCtD
Diazoxide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0035	0.00625	CcSEcCtD
Diazoxide—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00346	0.0205	CbGpPWpGaD
Diazoxide—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.00614	CcSEcCtD
Diazoxide—GLUL—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00342	0.0202	CbGpPWpGaD
Diazoxide—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00337	0.00602	CcSEcCtD
Diazoxide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00336	0.00601	CcSEcCtD
Diazoxide—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00335	0.00599	CcSEcCtD
Diazoxide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00332	0.00593	CcSEcCtD
Diazoxide—CA2—lung—chronic obstructive pulmonary disease	0.00323	0.0119	CbGeAlD
Diazoxide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00319	0.0057	CcSEcCtD
Diazoxide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00317	0.00565	CcSEcCtD
Diazoxide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00312	0.00557	CcSEcCtD
Diazoxide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00312	0.00557	CcSEcCtD
Diazoxide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00306	0.00547	CcSEcCtD
Diazoxide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00294	0.00526	CcSEcCtD
Diazoxide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00525	CcSEcCtD
Diazoxide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00525	CcSEcCtD
Diazoxide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00285	0.0051	CcSEcCtD
Diazoxide—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.00283	0.00506	CcSEcCtD
Diazoxide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00281	0.00502	CcSEcCtD
Diazoxide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00279	0.00499	CcSEcCtD
Diazoxide—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00498	CcSEcCtD
Diazoxide—GLUL—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00278	0.0165	CbGpPWpGaD
Diazoxide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00278	0.00496	CcSEcCtD
Diazoxide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00495	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.00276	0.0163	CbGpPWpGaD
Diazoxide—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00479	CcSEcCtD
Diazoxide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00267	0.00478	CcSEcCtD
Diazoxide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00265	0.00473	CcSEcCtD
Diazoxide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00264	0.00471	CcSEcCtD
Diazoxide—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00469	CcSEcCtD
Diazoxide—GLUL—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00262	0.0155	CbGpPWpGaD
Diazoxide—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00466	CcSEcCtD
Diazoxide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00258	0.0046	CcSEcCtD
Diazoxide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00256	0.00457	CcSEcCtD
Diazoxide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00454	CcSEcCtD
Diazoxide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00252	0.0045	CcSEcCtD
Diazoxide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00246	0.0044	CcSEcCtD
Diazoxide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00246	0.0044	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00245	0.0145	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00245	0.0145	CbGpPWpGaD
Diazoxide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00244	0.00436	CcSEcCtD
Diazoxide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00244	0.00436	CcSEcCtD
Diazoxide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00243	0.00435	CcSEcCtD
Diazoxide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00242	0.00433	CcSEcCtD
Diazoxide—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00433	CcSEcCtD
Diazoxide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.00431	CcSEcCtD
Diazoxide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00238	0.00424	CcSEcCtD
Diazoxide—GLUL—Amino acid and derivative metabolism—GCLC—chronic obstructive pulmonary disease	0.00234	0.0138	CbGpPWpGaD
Diazoxide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.00417	CcSEcCtD
Diazoxide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0023	0.00411	CcSEcCtD
Diazoxide—Cataract—Prednisone—chronic obstructive pulmonary disease	0.00228	0.00407	CcSEcCtD
Diazoxide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.00401	CcSEcCtD
Diazoxide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00399	CcSEcCtD
Diazoxide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00399	CcSEcCtD
Diazoxide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00393	CcSEcCtD
Diazoxide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00391	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00218	0.0129	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00218	0.0129	CbGpPWpGaD
Diazoxide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00217	0.00388	CcSEcCtD
Diazoxide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.00388	CcSEcCtD
Diazoxide—GLUL—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00213	0.0126	CbGpPWpGaD
Diazoxide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.0038	CcSEcCtD
Diazoxide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00213	0.0038	CcSEcCtD
Diazoxide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00211	0.00377	CcSEcCtD
Diazoxide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00377	CcSEcCtD
Diazoxide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00208	0.00372	CcSEcCtD
Diazoxide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00371	CcSEcCtD
Diazoxide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00371	CcSEcCtD
Diazoxide—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00206	0.00368	CcSEcCtD
Diazoxide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00366	CcSEcCtD
Diazoxide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00366	CcSEcCtD
Diazoxide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00366	CcSEcCtD
Diazoxide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00365	CcSEcCtD
Diazoxide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00365	CcSEcCtD
Diazoxide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00204	0.00365	CcSEcCtD
Diazoxide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00204	0.00365	CcSEcCtD
Diazoxide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00362	CcSEcCtD
Diazoxide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00362	CcSEcCtD
Diazoxide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00359	CcSEcCtD
Diazoxide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.002	0.00357	CcSEcCtD
Diazoxide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00199	0.00356	CcSEcCtD
Diazoxide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00351	CcSEcCtD
Diazoxide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00351	CcSEcCtD
Diazoxide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00351	CcSEcCtD
Diazoxide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00346	CcSEcCtD
Diazoxide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00345	CcSEcCtD
Diazoxide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00344	CcSEcCtD
Diazoxide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00192	0.00344	CcSEcCtD
Diazoxide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00192	0.00343	CcSEcCtD
Diazoxide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00192	0.00343	CcSEcCtD
Diazoxide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00342	CcSEcCtD
Diazoxide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.0034	CcSEcCtD
Diazoxide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00188	0.00337	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00188	0.0111	CbGpPWpGaD
Diazoxide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00331	CcSEcCtD
Diazoxide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00328	CcSEcCtD
Diazoxide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00328	CcSEcCtD
Diazoxide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00328	CcSEcCtD
Diazoxide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00183	0.00326	CcSEcCtD
Diazoxide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.00323	CcSEcCtD
Diazoxide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00179	0.0032	CcSEcCtD
Diazoxide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.0032	CcSEcCtD
Diazoxide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00317	CcSEcCtD
Diazoxide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00317	CcSEcCtD
Diazoxide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00316	CcSEcCtD
Diazoxide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00316	CcSEcCtD
Diazoxide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00314	CcSEcCtD
Diazoxide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00311	CcSEcCtD
Diazoxide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.0031	CcSEcCtD
Diazoxide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00309	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.00173	0.0102	CbGpPWpGaD
Diazoxide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00308	CcSEcCtD
Diazoxide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.00305	CcSEcCtD
Diazoxide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.00304	CcSEcCtD
Diazoxide—Pain—Formoterol—chronic obstructive pulmonary disease	0.00168	0.003	CcSEcCtD
Diazoxide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.003	CcSEcCtD
Diazoxide—KCNMA1—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.00168	0.00992	CbGpPWpGaD
Diazoxide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.003	CcSEcCtD
Diazoxide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00298	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00166	0.0098	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00165	0.00977	CbGpPWpGaD
Diazoxide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00294	CcSEcCtD
Diazoxide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00293	CcSEcCtD
Diazoxide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00292	CcSEcCtD
Diazoxide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00291	CcSEcCtD
Diazoxide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00291	CcSEcCtD
Diazoxide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00289	CcSEcCtD
Diazoxide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00289	CcSEcCtD
Diazoxide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00162	0.00289	CcSEcCtD
Diazoxide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00288	CcSEcCtD
Diazoxide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00288	CcSEcCtD
Diazoxide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00287	CcSEcCtD
Diazoxide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00287	CcSEcCtD
Diazoxide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00283	CcSEcCtD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.00159	0.00938	CbGpPWpGaD
Diazoxide—KCNJ11—Type II diabetes mellitus—TNF—chronic obstructive pulmonary disease	0.00158	0.00935	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00281	CcSEcCtD
Diazoxide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00277	CcSEcCtD
Diazoxide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00277	CcSEcCtD
Diazoxide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00277	CcSEcCtD
Diazoxide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00277	CcSEcCtD
Diazoxide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00277	CcSEcCtD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.00154	0.00909	CbGpPWpGaD
Diazoxide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00274	CcSEcCtD
Diazoxide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00274	CcSEcCtD
Diazoxide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00274	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00153	0.00906	CbGpPWpGaD
Diazoxide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00273	CcSEcCtD
Diazoxide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00272	CcSEcCtD
Diazoxide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00272	CcSEcCtD
Diazoxide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00272	CcSEcCtD
Diazoxide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00271	CcSEcCtD
Diazoxide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00269	CcSEcCtD
Diazoxide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.00268	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00148	0.00876	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00147	0.00871	CbGpPWpGaD
Diazoxide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00262	CcSEcCtD
Diazoxide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00262	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00145	0.00857	CbGpPWpGaD
Diazoxide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00259	CcSEcCtD
Diazoxide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00259	CcSEcCtD
Diazoxide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00258	CcSEcCtD
Diazoxide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00256	CcSEcCtD
Diazoxide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00253	CcSEcCtD
Diazoxide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00252	CcSEcCtD
Diazoxide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00252	CcSEcCtD
Diazoxide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00248	CcSEcCtD
Diazoxide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00248	CcSEcCtD
Diazoxide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00247	CcSEcCtD
Diazoxide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00244	CcSEcCtD
Diazoxide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00243	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00136	0.00804	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.00135	0.00801	CbGpPWpGaD
Diazoxide—KCNMA1—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.00135	0.00798	CbGpPWpGaD
Diazoxide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.0024	CcSEcCtD
Diazoxide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00134	0.0024	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00134	0.00791	CbGpPWpGaD
Diazoxide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00238	CcSEcCtD
Diazoxide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00238	CcSEcCtD
Diazoxide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00235	CcSEcCtD
Diazoxide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00234	CcSEcCtD
Diazoxide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00232	CcSEcCtD
Diazoxide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00232	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.0013	0.00767	CbGpPWpGaD
Diazoxide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00227	CcSEcCtD
Diazoxide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00227	CcSEcCtD
Diazoxide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00223	CcSEcCtD
Diazoxide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00223	CcSEcCtD
Diazoxide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Diazoxide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Diazoxide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Diazoxide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Diazoxide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00221	CcSEcCtD
Diazoxide—GLUL—Metabolism—APIP—chronic obstructive pulmonary disease	0.00123	0.0073	CbGpPWpGaD
Diazoxide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.0022	CcSEcCtD
Diazoxide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00123	0.0022	CcSEcCtD
Diazoxide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00219	CcSEcCtD
Diazoxide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00219	CcSEcCtD
Diazoxide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00219	CcSEcCtD
Diazoxide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00219	CcSEcCtD
Diazoxide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00217	CcSEcCtD
Diazoxide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00217	CcSEcCtD
Diazoxide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00216	CcSEcCtD
Diazoxide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00215	CcSEcCtD
Diazoxide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00211	CcSEcCtD
Diazoxide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.0021	CcSEcCtD
Diazoxide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00209	CcSEcCtD
Diazoxide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00209	CcSEcCtD
Diazoxide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00208	CcSEcCtD
Diazoxide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00208	CcSEcCtD
Diazoxide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00208	CcSEcCtD
Diazoxide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00204	CcSEcCtD
Diazoxide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00201	CcSEcCtD
Diazoxide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00197	CcSEcCtD
Diazoxide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00196	CcSEcCtD
Diazoxide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00195	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00109	0.00645	CbGpPWpGaD
Diazoxide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00194	CcSEcCtD
Diazoxide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.0019	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00106	0.00625	CbGpPWpGaD
Diazoxide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00186	CcSEcCtD
Diazoxide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00184	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.00102	0.00601	CbGpPWpGaD
Diazoxide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00101	0.0018	CcSEcCtD
Diazoxide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000962	0.00172	CcSEcCtD
Diazoxide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000955	0.00171	CcSEcCtD
Diazoxide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00091	0.00163	CcSEcCtD
Diazoxide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000893	0.0016	CcSEcCtD
Diazoxide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000879	0.00157	CcSEcCtD
Diazoxide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000877	0.00157	CcSEcCtD
Diazoxide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000854	0.00153	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000845	0.00499	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000832	0.00492	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.00082	0.00485	CbGpPWpGaD
Diazoxide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000818	0.00146	CcSEcCtD
Diazoxide—GLUL—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000818	0.00483	CbGpPWpGaD
Diazoxide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000804	0.00144	CcSEcCtD
Diazoxide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000797	0.00142	CcSEcCtD
Diazoxide—GLUL—Metabolism—GC—chronic obstructive pulmonary disease	0.000795	0.0047	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000787	0.00465	CbGpPWpGaD
Diazoxide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000784	0.0014	CcSEcCtD
Diazoxide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000774	0.00457	CbGpPWpGaD
Diazoxide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000773	0.00138	CcSEcCtD
Diazoxide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000755	0.00135	CcSEcCtD
Diazoxide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000747	0.00134	CcSEcCtD
Diazoxide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000742	0.00439	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000739	0.00437	CbGpPWpGaD
Diazoxide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000737	0.00132	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000721	0.00427	CbGpPWpGaD
Diazoxide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000704	0.00126	CcSEcCtD
Diazoxide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000699	0.00125	CcSEcCtD
Diazoxide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000694	0.00124	CcSEcCtD
Diazoxide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000672	0.0012	CcSEcCtD
Diazoxide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000671	0.0012	CcSEcCtD
Diazoxide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00067	0.0012	CcSEcCtD
Diazoxide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000667	0.00119	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000663	0.00392	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000647	0.00383	CbGpPWpGaD
Diazoxide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000637	0.00114	CcSEcCtD
Diazoxide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000632	0.00113	CcSEcCtD
Diazoxide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000632	0.00113	CcSEcCtD
Diazoxide—ABCC8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000631	0.00373	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—APIP—chronic obstructive pulmonary disease	0.000612	0.00362	CbGpPWpGaD
Diazoxide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000611	0.00109	CcSEcCtD
Diazoxide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000611	0.00109	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000584	0.00345	CbGpPWpGaD
Diazoxide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00057	0.00102	CcSEcCtD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000568	0.00336	CbGpPWpGaD
Diazoxide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000555	0.000991	CcSEcCtD
Diazoxide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000547	0.000977	CcSEcCtD
Diazoxide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000945	CcSEcCtD
Diazoxide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000513	0.00303	CbGpPWpGaD
Diazoxide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000511	0.000913	CcSEcCtD
Diazoxide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	0.000499	0.00295	CbGpPWpGaD
Diazoxide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000878	CcSEcCtD
Diazoxide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000491	0.00291	CbGpPWpGaD
Diazoxide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000487	0.000871	CcSEcCtD
Diazoxide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000487	0.00087	CcSEcCtD
Diazoxide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000484	0.000865	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000481	0.00284	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000481	0.00284	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	0.000478	0.00283	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000464	0.00274	CbGpPWpGaD
Diazoxide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000459	0.00082	CcSEcCtD
Diazoxide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000444	0.00263	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000435	0.00257	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000429	0.00254	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000418	0.00247	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000417	0.00247	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000409	0.00242	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GC—chronic obstructive pulmonary disease	0.000406	0.0024	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000405	0.0024	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GC—chronic obstructive pulmonary disease	0.000394	0.00233	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000392	0.00232	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000378	0.00223	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000376	0.00222	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000366	0.00217	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000361	0.00214	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000344	0.00204	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000324	0.00192	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000317	0.00187	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000316	0.00187	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000315	0.00186	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000302	0.00179	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000301	0.00178	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000297	0.00176	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000289	0.00171	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000289	0.00171	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000277	0.00164	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000272	0.00161	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000269	0.00159	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.00155	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000261	0.00154	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000258	0.00153	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000246	0.00145	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000236	0.00139	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.00134	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000222	0.00131	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000219	0.0013	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000218	0.00129	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00128	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000215	0.00127	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000213	0.00126	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	0.0002	0.00118	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.0002	0.00118	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000195	0.00115	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000194	0.00115	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000189	0.00112	CbGpPWpGaD
Diazoxide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000186	0.0011	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00109	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000181	0.00107	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00106	CbGpPWpGaD
Diazoxide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000179	0.00106	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ALB—chronic obstructive pulmonary disease	0.000178	0.00105	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000173	0.00103	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000171	0.00101	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000166	0.000983	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000165	0.000973	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.000972	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.000932	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000154	0.00091	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000152	0.000897	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000149	0.000882	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000147	0.00087	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000141	0.000836	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000137	0.000811	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.000793	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.000769	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000112	0.000661	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000107	0.000634	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000107	0.000632	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000103	0.000606	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	9.11e-05	0.000539	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	8.84e-05	0.000523	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	8.72e-05	0.000515	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	8.45e-05	0.0005	CbGpPWpGaD
